32
Participants
Start Date
April 9, 2021
Primary Completion Date
July 8, 2025
Study Completion Date
July 8, 2025
Ropivacaine 0.2% Injectable Solution
Patients in the intervention group will have ultrasound guided bilateral T3 paravertebral catheters placed prior to surgery. Prior to surgery, these patients will have 5ml of 1.5% lidocaine with 1:200,000 epinephrine injected in each catheter. Ropivacaine 0.2% will be administered via programmed intermittent bolus of 7ml every 60 minutes through each catheter during and after surgery.
University of Minnesota, Minneapolis
University of Minnesota
OTHER